Vertebrate endoderm development has recently become the focus of intense investigation. We have identi®ed a novel sox gene, 226D7, which is important in zebra®sh endoderm development. 226D7 was isolated by an in situ hybridization screening for genes expressed in the yolk syncytial layer (YSL) at the blastula stage. 226D7 is expressed mainly in the YSL at this stage and, during gastrulation, its expression is also detected in the forerunner cells and endodermal precursor cells. The expression of 226D7 is positively regulated by Nodal signaling. The knockdown of 226D7 using morpholino antisense oligonucleotides results in a lack of sox17-expressing endodermal precursor cells during gastrulation, and, consequently, lacks endodermal derivatives such as gut tissue. The effect is strictly restricted to the endodermal lineage, while the mesoderm is normally formed, a phenotype that is nearly identical to that of the casanova mutant (Dev. Biol. 215 (1999) 343). We further demonstrate that overexpression of 226D7 increases the number of sox17-expressing endodermal progenitor cells without upregulating the expression of the Nodal genes, cyclops and squint. Region-speci®c knockdown and overexpression of 226D7 by injection into the YSL suggest that 226D7 in the YSL is not involved in endoderm formation and 226D7 in the endoderm progenitor cells is important for endoderm development. Taken together, our data demonstrate that 226D7 is a downstream target of Nodal signal and a critical transcriptional regulator of early endoderm formation. q
Introduction
The formation of the vertebrate body plan begins with the segregation of cells into three germ layers: ectoderm, mesoderm and endoderm. The molecular mechanisms underlying ectoderm and mesoderm formation and patterning have been studied extensively. However, our understanding of endoderm formation has only begun to progress recently by molecular and genetic analyses in Xenopus and zebra®sh.
In Xenopus, the endoderm forms during gastrulation from the yolky embryonic vegetal pole. Several genes have already been reported to play critical roles in endoderm formation in Xenopus. An initial player in Xenopus endoderm formation is a maternally supplied T-Box transcription factor, VegT. Ectopic expression of VegT in animal caps induces the expression of several endodermal markers (Horb and Thomsen, 1997) , while depletion of the vegetally localized maternal deposit of VegT using antisense oligonucleotides blocks endoderm formation entirely (Zhang et al., 1998b) . In addition, a few Mix homeobox genes such as Mixer and Milk have been shown to be expressed in the presumptive endoderm and play important roles in endoderm formation in Xenopus (Henry and Melton, 1998; Ecochard et al., 1998) . One of the downstream targets of Mix genes appears to be a Xenopus homolog of murine Sox17, Xenopus Sox17 (Sox17a and Sox17b, here referred to collectively as Sox17; Hudson et al, 1997) . Xenopus Sox17, a HMG box-containing transcription factor, is expressed in the endodermal lineage and induces endodermal markers in the animal cap. Furthermore, endodermal development is blocked in embryos expressing a dominant inhibitory mutant of Sox17 (Xenopus Sox17-enR; Hudson et al., 1997) . Recent studies using zebra®sh mutants have clearly demonstrated important roles of a Mix family protein in endoderm formation and its action through Sox17 Kikuchi et al., 2000) .
In zebra®sh, endoderm and mesoderm precursors are distributed throughout the margin of the blastoderm and often share a common precursor (Warga and Nusslein-Volhard, 1999) . At the late gastrula stage, endodermal cells become characterisitically large and¯at, distinct from the rounder mesodermal cells (Warga and Nusslein-Volhard, 1999) . In zebra®sh, sox17 is an excellent molecular marker for these endodermal progenitor cells . In zebra®sh, mutant screening have identi®ed several mutants that exhibit early endodermal defects, such as oep, casanova, bon/mix, and fau/gata5 (Schier et al., 1997; Kikuchi et al., 2000; Reiter et al., 1999 Reiter et al., , 2001 . In these mutants, sox17-expressing endodermal progenitor cells are reduced in number or lost at the gastrula stage Kikuchi et al., 2000; Reiter et al., 2001 ). All mutants other than oep act genetically downstream of Nodal signaling, while oep, which encodes an EGF-CFC family protein, is required for Nodal signaling Kikuchi et al., 2000; Reiter et al., 2001; Gritsman et al., 1999) . These genetic data indicate that Nodal signaling is crucial in zebra®sh endoderm development. Furthermore, in the double mutant zebra®sh for both cyclops (cyc) and squint (sqt), two genes that encode Nodal-related molecules, all of the endoderm and most of the mesoderm do not develop. Both genes are expressed in the blastoderm margin and, interestingly, sqt is expressed in the yolk syncytial layer (YSL), suggesting a role for the YSL in mesoderm and endoderm formation (Sampath et al., 1998; Rebagliati et al., 1998; Feldman et al., 1998) . In fact, transplantation experiments demonstrated that the extraembryonic yolk cell, especially the associated YSL, is capable of ectopically inducing mesoderm and endoderm when transplanted to the animal pole of a host embryo (Mizuno et al, 1996; Ober and Schulte-Merker, 1999; Rodaway et al., 1999) . Furthermore, injection of RNase into the yolk cell after the 1k-cell stage, which effectively eliminates YSL transcripts, results in a loss of ventrolateral mesoderm and endoderm (Chen and Kimelman, 2000) . These results support the idea that the mesoderm and endoderm, except for the most dorsal mesoderm, is induced by YSL-derived signals. However, the mechanism regulating the inducing activity of the YSL remains largely unknown.
In order to elucidate the molecular events that occur in the YSL before and during induction of mesoendoderm, we have developed a technique to isolate genes that are expressed there. The technique consists of in situ hybridization screening and a yolk-cell enriched cDNA library. During the course of the screening, we have isolated a novel sox gene, 226D7, whose expression is detected mainly in the YSL at the blastula stage, to include later the endodermal progenitors and forerunner cells. Surprisingly, knockdown of 226D7 by a morpholino antisense technique results in complete suppression of endoderm development without affecting the mesoderm. The expression and functional analyses in wild-type and mutant embryos demonstrate that 226D7 is a downstream target of Nodal signal and is a potent inducer of endodermal markers, including sox17. However, injection of 226D7 morpholino or RNAs encoding 226D7 into the YSL did not affect the formation of mesoendoderm. Thus, 226D7 expressed in the blastoderm margin and endodermal progenitors functions as a key regulator of endoderm formation downstream of Nodal signaling.
Results

Isolation of 226D7, a novel sox gene
We are now carrying out in situ hybridization screening for novel genes expressed in the zebra®sh YSL. The methods and results of these studies will be reported elsewhere. During the course of the current investigation, we isolated a cDNA fragment, 226D7, which is expressed strongly in the YSL at the dome stage. This 0.4 kb-long fragment has an ORF with no similarities to other known sequences. The corresponding full-length cDNA was cloned by a combination of cDNA library screening and 5 H RACE (see Section 4). The full-length 226D7 cDNA, which consists of 1230 base pairs (bp), encodes a novel transcription factor of the Sox family (Fig. 1A) . 226D7, which is 307 amino-acids long, contains one HMG DNA binding domain (Fig. 1A,B) . A database search with full-length 226D7 showed similarities to other Sox proteins such as Xenopus Sox17 not only in the HMG domain but also in the C-terminal region (blue box and pink underlined region in Fig. 1B ). The 226D7 HMG domain exhibits 69, 68, 67, 71, 62, 64, 53 , and 48% identity to those of mouse Sox17 (Kanai et al., 1996) , Xenopus Sox17a, Xenopus Sox17a (Hudson et al., 1997) , Xenopus Sox7 (Shiozawa et al., 1996) , Drosphila Sox50E (Russell et al., unpublished data), zebra®sh Sox17 , mouse Sox1 (Nishiguchi et al., 1998; Pevny et al. 1998) , and human SRY (Poulat et al., 1997) , respectively (Fig.  1C) . The sequence motif RPMNAF in the HMG domain (positions 5±10) is conserved in all reported Sox family members (Bowles et al., 2000) . The extended version of this motif, RPMNAFMVW, is proposed to be the most reliable signature of the Sox family (Bowles et al., 2000) . However, the HMG domain of 226D7 has three amino acid substitutions in this motif (RPMNAFMVW changed to RPLNAFIIW; Fig. 1C) .
To examine the relationship between the 226D7 and other Sox family proteins, a phylogenetic tree was constructed using multiple alignments of homologous proteins. As shown in Fig. 1D , 226D7 is classi®ed as a Group F protein. However, 226D7 is relatively distant from other vertebrate Group F members. Thus, we concluded that 226D7 is a novel Sox transcription factor, which is related to the Group F subfamily of Sox transcription factors.
Expression and regulation of 226D7 during zebra®sh embryogenesis
Whole-mount in situ hybridization with digoxigeninlabeled probes was performed to examine the embryonic expression pattern of 226D7. The transcripts are initially detected as a faint staining pattern in dorsal blasotmeres and the dorsal YSL at the sphere stage (data not shown). At the dome stage, dorsal blastomeres and the entire external YSL express 226D7 (Fig. 2A) . By 30%-epiboly, 226D7 expression begins to extend to subsets of cells in the surrounding marginal region. According to their location, these cells seem to be progenitors of endodermal cells (see below; Fig. 2B,C,I ). At the shield stage, 226D7 is expressed in forerunner cells (arrowhead in Fig. 2D : a specialized dorsal subset of endoderm, Cooper and D'Amico, 1996) , endoderm progenitor cells, and the YSL (Fig. 2D,E) . At this stage, the expression pattern of 226D7 is very similar to that of zebra®sh sox17, an endodermal marker, except for the expression in the YSL, indicating that 226D7-positive cells in the blastoderm are endoderm progenitors . The expression pattern is largely unchanged during gastrulation and 226D7 continues to be expressed in the endoderm precursors, forerunner cells, and YSL (Fig. 2F,G) . The region of expression in the YSL has an anterior boundary in the internal region and the most anterior portion of the internal YSL does not express 226D7 (data not shown). All expression, except for in the forerunner cells, disappears by the tailbud stage (Fig. 2H) . Thereafter, no positive signal is detected during embryonic development.
Nodal signaling has been shown to play important roles in Xenopus and zebra®sh endoderm formation (Yasuo and Lemaire, 1999; Osada and Wight, 1999; Feldman et al., 1998) . Since 226D7 is expressed in endodermal precursors, we reasoned that 226D7 expression could be regulated by Nodal signaling. To verify this hypothesis, we examined the 226D7 expression pattern in zygotic oep mutants and antivin-RNA-injected embryos (Zhang et al., 1998a; Gritsman et al., 1999; Thisse and Thisse, 1999; Thisse et al., 2000) . In the zygotic oep mutant, in which Nodal signaling is greatly reduced, 226D7 expression in the endodermal precursor cells is nearly lost, although expression is still detected in the forerunner cells and YSL at the gastrula stage (Fig.  2K,M) . A more severe reduction in 226D7 expression was observed in embryos injected with 25 pg/embryo RNA encoding Antivin, a competitive Nodal inhibitor. The antivin-injected embryo that mimics the phenotype of the maternal zygotic oep mutant, is thought to completely lack Nodal signaling (Thisse et al., 2000) . In injected embryos, only YSL expression remains intact, while expression in forerunner cells and endoderm precursors is abolished throughout development (Fig. 2J,L,N) . Conversely, injection of RNA (6 pg/embryo) encoding the zebra®sh Nodal gene, squint, upregulates 226D7 expression in the blastomeres (Fig. 2O; Feldman et al., 1998) . Altogether, the results indicate that 226D7 expression in endoderm precursors and forerunner cells is positively regulated by Nodal signaling.
Morpholino knockdown of 226D7 leads to a complete loss of endoderm
To analyze the function of 226D7 during embryogenesis, we applied morpholino antisense translation inhibition to zebra®sh embryos. The technique has been shown to work well in zebra®sh: when injected, morpholino-modi®ed antisense oligonucleotides effectively and speci®cally block translation of the corresponding mRNAs (see Section 2.7; Nasevicius and Ekker, 2000; Ross et al., 2001; Bauer et al., 2001) . We designed antisense oligonucleotides against the putative translation initiation site of 226D7, using oligonucleotides with the inverted sequence as a control (see (Saitou and Nei, 1987) using the amino acid sequence of HMG domains. Sox proteins are classi®ed into 10 groups based upon a difference in the sequence of the HMG domain and in overall domain structures. Each Sox protein is printed in a speci®c color, which represents each subgroup (six major groups out of 10 are chosen for simplicity).
Section 4). The injection of control morpholino oligonucleotides did not affect embryonic development ( Fig.  3A ,B; 72% (dead 9%), n 55). In contrast, injection of 226D7 morpholino oligonucleotides (226D7 MO) reproducibly resulted in several speci®c defects when examined at the 38-h stage ( Fig. 3C ,D; 76% (dead 16%), n 25). These embryos have a thickened yolk sac (asterisk in Fig. 3C ) but no opened anus, intestine (arrow and high magni®cation view panel in Fig. 3C ) and ventral tail ®n (arrowhead in Fig. 3C ). Furthermore, they seem to have defects in the migration of heart progenitor cells to the midline, as evidenced by the frequent observation of two symmetric beating hearts (Fig. 3D ). This phenotype, referred to as cardia bi®da (Stainier, 2001) , could be a result of endoderm defects after injection of 226D7 MO; some mutants with this phenotype (Stainier et al., 1996; Chen et al., 1996) have defects in endoderm formation at earlier stages Reiter et al., 2001; Kikuchi et al., 2000; Stainier, 2001 ). Indeed, 226D7-MO-injected embryos lack endoderm-derived tissues such as intestine. These data prompted us to determine if endoderm development is affected by injection of 226D7 MO.
As expected, we found that shh expression in the endoderm region, but not in the¯oor-plate region, is absent in 226D7-MO-injected embryos at the 38-h stage ( Fig. 4A±D ; Krauss et al., 1993) . This demonstrates that 226D7 is involved in endoderm formation and suppression of 226D7 function results in a loss or reduction of endodermal derivatives. Since 226D7 is expressed before the 38 h-stage, we examined endoderm formation in 226D7-MO injected embryos at the gastrula stage to determine when the endoderm abnormality arises. We found that gata-5 expression in endodermal progenitor cells, but not in the YSL, is strongly reduced or absent in the 226D7-MO-injected embryos at 80%-epiboly ( Fig. 4E,F ; Rodaway et al., 1999) . Similarly, expression of zebra®sh sox17, which is the earliest endodermal marker, completely disappears after 226D7-MO injection (Fig. 4G,H; . sox17 expression was never detected, even at the shield stage when sox17 begins to be activated in endodermal precursors (Fig. 4I,J) . We also examined 226D7 expression after 226D7-MO injection and found that 226D7 expression is greatly reduced or lost in the endodermal progenitor cells, while its expression in the YSL tends to be upregulated during gastrulation (Fig. 4K ). These data demonstrate that the endoderm does not form when the function of 226D7 is suppressed.
226D7 is expressed in endodermal progenitor cells, forerunner cells and the YSL. To determine which group of 226D7-expressing cells is responsible for endoderm formation, we injected 226D7-MO into the YSL at the 1k-cell stage. However, the injection did not affect the expression of sox17 (Fig. 4L ) and no morphological defects were observed at the 38-h stage ( Table 1 ), suggesting that 226D7 in the YSL is not involved in endoderm development. Thus, 226D7 in endodermal progenitors has an important role in endoderm formation.
Since both gata5 and sox17 are regulated by Nodal signaling Reiter et al., 2001; , the effect of 226D7-MO injection could be caused by downregulation of the Nodal genes cyclops (cyc) and squint (sqt). To test this possibility, we examined cyc and sqt expression in 226D7-MO-injected embryos. 226D7, however, did not affect the expression of cyc or sqt (Fig. 4M±P) , indicating that 226D7 directly acts on endodermal markers and functions downstream of Nodal signaling.
Early dorsoventral markers in 226D7-knockdown embryos
226D7-injected embryos at the 38-h stage lack the ventral tail ®n (Fig. 3C ). This phenotype is commonly seen in weakly dorsalized zebra®sh mutants . In spite of this, we did not observe any signi®cant change in the expression of early ventral markers such as gata2 and zbmp2 after 226D7-MO injection ( Fig. 4Q,R ; Detrich et al., 1995;  data not shown). Since overexpression of 226D7 frequently caused the accumulation of blood cells near the anus (see below), we examined gata1 expression, a hema- topoietic marker, in 226D7-MO-injected embryos. At the 7-somite stage, gata1 is exclusively expressed in hematopoietic progenitors located in the lateral plate ( Fig. 4S ; Detrich et al., 1995) . The expression pattern of gata1 is largely unchanged after injection of 226D7 MO. However, we noticed that the interval between two bilateral expression stripes in 226D7-MO-injected embryos tends to be narrower (Fig. 4S,T) . Since, at this stage, gata1 is expressed in lateral plate mesoderm, this phenotype could be caused by affected cell migration during dorsal convergence, probably due to endoderm defects.
Overexpression of 226D7 produces morphological defects in 38-h embryos
Since functional suppression of 226D7 resulted in speci®c defects in the endoderm, we expected that augmentation of 226D7 could also affect endodermal development. To verify this idea, we overexpressed 226D7 protein by injecting capped RNA into one-cell stage zebra®sh embryos. However, high-dose injection of 226D7 RNA (.100 pg/ embryo) severely affected development and completely inhibited epiboly movement (data not shown). Since 226D7-knockdown embryos never showed an epiboly defect, we lowered the concentration of injected RNAs and found that 3 pg 226D7 RNA/embryo produced speci®c phenotypes at the 38-h stage without affecting the epiboly. Thus, low-dose injections were mainly applied in the following experiments.
We classi®ed the resulting phenotypes at 38-h stage into three classes: Class I, Class II, and Class III (Fig. 5B±D , Table 2 ). The weakest phenotype, Class I, exhibits an accumulation of blood cells near the anus (Fig. 5B ) that could be a result of the expansion of blood islands or circulation defects. In the intermediate phenotype, Class II, in addition to blood cell accumulation, head structures become smaller (Fig. 5C ). These phenotypes are similar to ventralized mutants in zebra®sh . Class III, the most frequent and severe form, includes accumulated blood cells, smaller head structures, and a curly-tail up phenotype (Fig. 5D ).
226D7 upregulates sox17 in a Nodal-independent manner
We hypothesized that the above phenotypes at the 38-h stage could be due to early endodermal defects, and examined injected embryos at earlier stages. As expected, sox17 was upregulated greatly in 226D7-injected embryos at 60%-epiboly (Fig. 6A±C) . Both the number of sox17-expressing cells and the intensity of expression greatly increase after injection of 226D7 RNA. However, most sox17-expressing cells were still found near the margin (Fig. 6B,C) . In a few extreme cases, dot-like sox17 signals were seen in the animal-pole region in addition to increased expression near the margin (data not shown). Similar to 226D7 MO, injection of 226D7 RNAs into the YSL (even at 12 pg/ embryo) at the 1k-cell stage did not change either sox17 expression at 70%-epiboly or the external morphology at the 38-h stage ( Fig. 6D and Table 1 ). This result is consistent with the idea that 226D7 in endodermal precursors is critical for endoderm development. Since sox17 expression is regulated by Nodal, it could be possible that 226D7 overexpression acts through upregulation of Nodal genes. To examine this, we co-injected 226D7 and antivin RNAs. The injection of 25 pg/embyo antivin RNAs is thought to completely block Nodal signaling (Thisse and Thisse, 1999; Thisse et al., 2000) and those injected embryos lack entire sox17 expression ( Fig. 6E ; . In co-injection of 25 pg of antivin-RNA and 3 pg/embryo of 226D7-RNA, sox17 expression was restored, although the spatial restriction of ectopic sox17 induction was lost (Fig. 6F : compare with B,C), suggesting that 226D7 acts directly on endodermal precursors. We then investigated the expression of the Nodal genes, cyc and sqt, in 226D7-injected embryos, and found that, when overexpressed, 226D7 downregulates both cyc and sqt expression in the marginal blastomeres (Fig.  6G,H) . These data are consistent with the idea that 226D7 directly upregulates endodermal markers. The downregulation of marginal cyc and sqt expression could be due to a conversion of cell fate from mesoderm to endoderm in the margin. In support of this, we observed a weak reduction in no tail (ntl; Fig. 6K ,L; Schulte-Merker et al., 1992) expression after 226D7 injection.
Since the injected embryos showed weak ventralized phenotypes at the 38-h stage (Fig. 5C ), we next examined the dorsoventral patterning of gastrula embryos injected with 226D7 RNA. The expression pattern of chordin at 30%-epiboly did not change (data not shown), suggesting that initial dorsoventral patterning is not affected in injected embryos. However, during gastrulation, expression of goosecoid (gsc) becomes reduced in overexpressed embryos ( Fig. 6M,N ; Stachel et al., 1993) . Consequently, gata2, which is normally expressed in the ventral half of the animal-pole region, expands dorsally and increases at 80%-epiboly after injection of 226D7 RNAs (Fig. 6O,P) . Similarly, the lateral border of bmp2 expression in the anterior±ventral epiblast dorsally shifts when examined at 80%-epiboly ( Fig. 6Q,R ; Nikaido et al., 1997) . These data indicate that 226D7, when overexpressed, ventralizes the embryo during gastrulation.
One of the obvious phenotypes at the 38-h stage is the accumulation of blood cells near the anus (Fig. 5B,C) . Thus, we examined the expression of gata1 in 226D7-injected embryos. The overexpression of 226D7 produced two major changes in gata1 expression; one is an expansion of the dorsal gap between two bilateral expression stripes (Fig.  6T ) and the other is a reduction in gata1 expression (data not shown). These two cases were observed at nearly the same frequency (6/13 for the former; 7/13 for the latter). The expansion of the gap contrasts with the phenotype observed following injection of 227D7 MO (Fig. 4T) , suggesting that endodermal cells affects cell movement of mesodermal cells during dorsal convergence. Since hematopoietic cells derive from the most ventral marginal mesoderm, a loss of gata1 expression in 226D7-injected embryos could be due to a fate change of the corresponding mesoderm to endoderm. More importantly, the absence of any expansion or increase in gata1 expression suggests that the blood accumulation observed in 38-h embryos injected with 226D7 RNAs may not caused by expansion of blood islands.
The speci®city of 226D7 morpholino antisense oligonucleotides
Although it is recommended that molipholino oligonucleotides are designed against the 5 H UTR, our 226D7 MO was constructed to bind to a sequence covering the ®rst methionine and ORF region because of low GC content in the 5 H UTR region of 226D7 cDNA. In order to demonstrate the speci®city of the 226D7 MO, we constructed a FLAGtag fused 226D7 construct, FLAG-226D7, in which the ®rst 19 amino acids of the 226D7 protein are switched to the FLAG tag (see Section 4; Fig. 7A ). We con®rmed that, like 226D7, injection of FLAG-226D7 RNA (13 pg/embryo) upregulates sox17 expression (Fig. 7C) , while injection of an identical amount of EGFP RNA has no effect (Fig. 7B) . We then co-injected 226D7 MO with FLAG-226D7 RNA and observed a rescue of sox17 expression (Fig. 7E) . By contrast, co-injection of 226D7 MO and EGFP RNA did (5) 11 (3) 42 (11) 8 (2) 12 ( not rescue sox17 expression (Fig. 7D) , indicating that our 226D7 MO functions in a sequence-speci®c manner.
In this experiment, we noticed that the expression pattern of sox17 in the rescued embryos (Fig. 7E) was different from FLAG-226D7-injected embryos (Fig. 7C) , although both embryos were injected with the same amount of RNAs. The rescued embryos exhibited uniform and elevated expression of sox17 in the entire embryo, while upregulation of sox17 was con®ned to the marginal region in the case of FLAG-226D7 or 226D7 injection. This pattern was reminiscent of that obtained by co-injection of antivin and 226D7 RNAs (Fig. 6F) . Since endogenous 226D7 was inactivated in these embryos, the results suggest that the initial level of endogenous 226D7 is important in restricting sox17 expression into the blastoderm margin.
Discussion
226D7 is a novel Sox family transcription factor
In this study, we cloned a novel sox gene, 226D7, which plays a critical role in endoderm formation. In Xenopus, Sox17 has also been shown to be involved in endoderm formation (Hudson et al., 1997) . Interestingly, Xenopus Sox17 and 226D7 both belong to the same subfamily of Sox transcription factors, called group F (Fig. 1D) . This similarity suggests that 226D7 is a zebra®sh ortholog of sox17. However, the following evidence refutes this hypothesis. First, the HMG domain of 226D7 is unique and has lower homology to other family member sequences. Although the HMG domain of 226D7 has the highest similarity to Xenopus Sox7, one of the group F Sox proteins, only 71% of the amino acids within the HMG domain are identical to each other. In contrast, at least 84% identity is seen between other vertebrate homologs of group F. Secondly, there are three amino acids substituted in the highly conserved region within the HMG domain of 226D7. This region is called the`Sox signature', and is conserved among Sox proteins (Bowles et al., 2000) . Thirdly, phylogenetic analysis of the sequence of the HMG domain reveals that 226D7 is relatively distantly related to other vertebrate members of group F (Fig. 1D) . We, therefore, conclude that 226D7 is a novel sox transcription factor that is related to group F. The isolation of the murine ortholog of 226D7 will be informative for revealing the conserved function of this novel Sox protein.
Outside the HMG domain, 226D7 exhibits similarity to other members of group F, especially in the C-terminal region (pink underline in Fig. 1B ). This conserved region could function as a transcriptional activator or repressor. As for the genomic structure, we found at least one intron in the middle of the HMG region of 226D7 (data not shown). This exon/intron structure is also conserved in the members of group F, strengthening the idea that 226D7 is closely related to that group (Bowles et al., 2000) . Mapping with a radiation hybrid panel (kindly provided by Dr M. Ekker) showed that 226D7 is located in LG7 (places 6.83cR from z20576).
226D7 is a necessary and suf®cient factor for endoderm development
The loss-of-function experiments with morpholino antisense oligonuceotides demonstrated that 226D7 is required for the formation of shh expressing endoderm at the 38-h stage as well as earlier sox17-expressing endodermal progenitors (Fig. 4A±D,I ,J). Since sox17 is thought to be expressed in all endodermal progenitors, we conclude that 226D7 is a necessary factor for formation of the entire endoderm . Furthermore, gain-of-function experiments show that 226D7 alone is suf®cient to induce sox17 (Fig. 6A±C) . Importantly, in embryos injected with 226D7 RNAs, elevated expression of endodermal markers appears to be accompanied by a reduction in mesodermal markers: ntl, cyc and gsc expres- sion is reduced in the blastoderm margin. This suggests that 226D7 is able to convert mesodermal cells into endodermal cells in this region. Furthermore, the action of 226D7 is independent of Nodal signaling because 226D7 induces sox17 in the presence of Antivin, a competitive Nodal inhibitor. Taken together, all data obtained so far support the idea that 226D7 is an essential regulator of endoderm formation.
226D7 is downstream of Nodal signaling and regulates endoderm development
Endoderm formation in zebra®sh requires Nodal signaling, as indicated by the lack of endodermal development in the cyc/sqt double mutant and maternal-zygote oep (MZ oep) mutant (Feldman et al., 1998; Gritsman et al., 1999) . In the present study, we show that 226D7 expression in the endoderm and forerunner cells is regulated by Nodal signaling. Consistent with this, injection of sqt elevates 226D7 expression. However, the endodermal precursors are more dependent on Nodal signaling than are forerunner cells, as demonstrated by the loss of 226D7 expression in the former, but not latter, cells in zygotic oep mutants (Fig. 2K,M) . Zygotic oep is thought to carry out the residual Nodal signaling that is initially mediated by maternally supplied Oep (Zhang et al., 1998a; Gritsman et al., 1999) . Consistent with this, overexpression of antivin-RNA, which completely blocks Nodal signaling, abolishes 226D7 expression both in the endoderm precursors and forerunner cells (Fig.  2J,L,N) .
In addition to endoderm, mesoderm development also depends on Nodal signaling: the axial and most lateral mesoderm is lost in MZ oep mutants (Gritsman et al., 1999) . Considering that knockdown of 226D7 does not affect mesoderm-derived tissues such as the notochord and somites, 226D7 appears to be a major downstream target of Nodal signaling speci®c for endoderm formation.
Does 226D7 in the YSL have any function in embryogenesis?
The YSL has been implicated in mesoderm and endoderm induction (Mizuno et al., 1996 (Mizuno et al., , 1999 Ober and SchulteMerker, 1999; Rodaway et al., 1999) . 226D7 was originally isolated as a gene expressed in the YSL. In fact, 226D7 is expressed ®rst in the dorsal YSL and dorsal marginal cells at the sphere stage, and, subsequently, its expression spreads to the entire YSL and the blastoderm margin. This led us to examine the role of 226D7 in the YSL by injecting 226D7 MO or 226D7 RNA into the YSL at the 1k-cell stage. However, the injection did not affect embryonic development at all (Table 1) . Since the YSL injection works well under our experimental conditions (in the case of sqt RNA injection, data not shown), the results suggest either that, in the YSL, 226D7 does not play a signi®cant role in embryogenesis, or that other factors may compensate or regulate the function of 226D7. Furthermore, its expression in the YSL is independent of Nodal signaling, although it is highly correlated with sqt expression (Feldman et al., 1998) . Thus, at the moment, the function of 226D7 in the YSL and the factor regulating the inducing ability of the yolk cell are still unclear. To address these questions, we will continue to search for novel genes expressed in the YSL by in situ hybridization screening.
Injection of 226D7-MO results in a phenocopy of the casanova mutant
Recently, several mutants have been reported to affect endoderm formation in zebra®sh: oep, bonnie and clyde (bon/mix), faust ( fau/gata5) and casanova (cas) (Schier et al., 1997; Kikuchi et al., 2000; Reiter et al., 2001; . The genes responsible for all these mutants, except for cas, have already been identi®ed (Zhang et al., 1998a; Kikuchi et al., 2000; Reiter et al., 1999) . In the bon and fau mutants, the number of sox17-expressing endodermal progenitor cells is greatly reduced (Kikuchi et al., 2000; Reiter et al., 2001) . Of the mutants, cas exhibits the most severe phenotype, and no sox17-expressing cells are detected throughout development . The phenotype of cas is reminiscent of 226D7-knockdown embryos in which essentially no sox17 expression is detected during gastrulation (Fig. 4H,J) . Although weakly dorsalized phenotypes were not reported in cas mutants, 226D7-knockdown embryos and cas mutants both exhibit many similarities in morphology and gene expression at later stages, including cardia bi®da, thickened yolk sac extension, a lack of anal opening and intestine and a loss of shh expression in endoderm derivatives . Thus, it is likely that 226D7 is the responsible gene for cas or the gene interacting with the cas pathway. Further genetic analyses focusing on the relationship between 226D7 and cas will be required.
3.6. Is 226D7 implicated in dorso-ventral patterning of the embryo?
The knockdown of 226D7 produces a weakly dorsalized phenotype including features such as a loss of a ventral tail ®n. Conversely, overexpression of 226D7 typically produces ventralized phenotypes such as the accumulation of blood cells and a small head. These data suggest that 226D7 could also be involved in dorsal±ventral patterning. However, we did not detect any signi®cant change in dorsal or ventral molecular markers in 226D7-knockdown embryos ( Fig. 4Q,R ; data not shown). In contrast, 226D7-overexpressed embryos show signi®cant dorsal expansion of ventral markers, bmp2 and gata2, which become evident during mid to late gastrula stage (Fig. 6O±R) , although initial dorsoventral patterning is unaffected. One possible explanation is that the effects of 226D7 overexpression are indirect and mediated by a fate change of dorsal mesoderm to the endoderm. Supporting this, a reduction in dorsal gsc expression was frequently observed in overexpressed embryos (Fig. 6N) . Furthermore, we frequently observed that the kupffer's vesicle, which derives from forerunner cells, expands in 226D7-injected embryos at the segmentation stage.
Nonethless, we cannot rule out the possibility of a direct action on dorsoventral patterning because Xenopus Sox17b was shown to interact directly with Xenopus b-catenin and downregulate its target gene (Zorn et al., 1999) . Considering the structural similarity between 226D7 and Sox17, it is also possible that 226D7 binds to b-catenin and downregulates its target genes. Further genetic and molecular analyses will be required to elucidate the role of 226D7 in dorso-ventral patterning.
Materials and methods
Fish embryos
Zebra®sh (Danio rerio) embryos were obtained form natural crosses of wild-type ®sh of the Oregon AB background or AB/TU heterozygote background. The oep mutant allele is oep tz257 . Collected embryos were maintained in 1/3 Ringer's solution (Sawada et al., 2000) at 28.58C and staged according to age (hours post-fertilization at 28.58C) and morphological criteria (Kimmel et al., 1995) .
Isolation and characterization of 226D7 cDNA
A fragment of the 226D7 clone was obtained by our in situ hybridization screening (screening methods and results will be reported elsewhere). To obtain the full-length cDNA, we isolated mRNA from segregated yolk cells (Mizuno et al., 1999) of dome-stage embryos using a QuickPrep Micro mRNA puri®cation kit (Amersham Pharmacia Biotech, Buckinghampshire, UK). The cDNA library was constructed using a SMART cDNA library construction kit (CLONTECH Laboratories, Inc., Palo Alto, CA). The yolk cell cDNA library was then screened with 0.4 kb of original 226D7 clone as a probe, resulting in a 1.0-kb clone containing a polyA tail. We further cloned the 5 H end region using a SMART RACE cDNA ampli®cation kit (CLONTECH). The entire sequence of 226D7 cDNA was found to be 1.2 kb long. eries of Japan, and by grants-in-aids from the Ministry of Education, Science, and Culture of Japan. T.S. is supported by the Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists.
